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ABSTRACT
INTRODUCTION: Coronary artery bypass graft (CABG) surgery that is a basic revascularization method is 
used commonly and hypertension appears frequently during and after CABG operations. In the treatment 
of hypertension, metaproterenol sulfate (MS) is one of the main agents; however, the effects of this agent 
on grafts are not known at an adequate level. The aim of the present study was to determine whether MS 
could be used safely in CABG operations by examining its effects on coronary grafts. 
MATERIAL AND METHODS: This cross-sectional, prospective, experimental study was conducted at a university 
hospital. In this study, internal thoracic artery (ITA), radial artery (RA) and saphenous vein (SV) graft materials 
were studied in organ bath in patients who underwent CABG surgery between 2013 and 2016. In the organ 
bath, 10-6 phenylephrine was added to the grafts to ensure that the ITA, RA and SV grafts contracted sub-
maximally. Then, by adding MS with the cumulative method, the resulting relaxation results were recorded 
and dose-response curves were created. The p < 0.05 was considered as significant.
RESULTS: A total of 30 patients were included in the study. The average age of the participants was 59.3  
(45–81) years. Minimum 1 and maximum 6 grafts (2.96 in average) were taken from all patients. Relaxation 
response was formed in the ITA at a rate of 40.49% ± 13.52, in the RA at a rate of 28.41% ± 9.08 and in 
the SV at a rate of 23.87% ± 8.36 by adding MS with the cumulative method. In the statistical work that 
was done by comparing the relaxation values among the SV grafts, ITA and RA grafts, it was determined 
that the efficacy of MS in the SV grafts was significantly lower when compared with the ITA and RA grafts.
CONCLUSIONS: In the present study, it was concluded that the risk of developing vasospasm was low in all 
three grafts when MS was used in intraoperative and postoperative periods. However, in the long-term, this 
made us consider that better graft patency rates might be obtained. Multicenter in-vivo studies with larger 
patient groups are needed to support our findings.
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INTRODUCTION
In patients who have atherosclerotic coronary artery 
disease, methods such as stenting, balloon angio-
plasty and coronary artery bypass graft (CABG) sur-
gery are known as the basic revascularization meth-
ods. CABG surgery was first used in late 1960s. The 
purpose in CABG operations is providing adequate 
blood-flow to the distal part of the heart vein where 
there is patency, providing blood to the ischemic 
myocardium in these areas, increasing the func-
tional capacity of the patient by providing better 
contractions in myocardium, and helping to increase 
the life quality and life expectancy of the patient. 
Today, CABG surgery is used commonly. 
A 42-year-old patient, who underwent coronary 
endarterectomy, received ‘bypass’ with saphenous 
vein (SV) grafts due to necessity. This anastomosis 
that was carried out by Johnson is considered as the 
first successful coronary bypass. After this period, the 
use of SV has become common. In the forthcoming 
years, the interest in it increased when it was shown 
that the patency rates of the internal thoracic artery 
(ITA) graft were higher than those of the SV grafts; 
and the use of ITA became 13% in early 1980s. In 
time, alternative arterial grafts were searched. Oper-
ations were performed in which other arterial grafts 
were used together with ITA, and complete arterial 
revascularization was obtained in this way. In our 
present time, ITA, radial artery (RA) and SV grafts 
are used commonly for CABG operations. One of 
the other grafts that may be used as autogenous 
grafts in CABG operations include gastroepiploic 
artery (GEA), inferior epigastric artery (IEA), splenic 
artery, subscapular artery, inferior mesenteric artery, 
lateral costal artery, and thoracodorsal artery [1]. In 
selecting the graft, the age and background of the 
patient, the location and spread of the involvement 
in coronary arteries, the condition of the vessel that 
may be used as the graft in the patient, and the 
opinion of the surgeon are influential. The structural 
and physiological characteristics of the graft that 
is employed in coronary artery ‘bypass’ operations 
have an important impact on the short- and long-
term patency rates. If the graft spasm that occurs in 
the early period of the operation due to mechanical 
or pharmacological reasons is not resolved, it may 
affect the graft patency negatively in the short and 
long term [2]. For this reason, the effects of the 
pharmacological agents used must be well-known. 
For this purpose, the effects of the pharmacological 
agents that are used must also be known well. For 
this reason, Green suggested papaverine injection to 
prevent spasm in IBA [3]. In case of necessity, proper 
relaxing agents may be administered to improve the 
graft blood-flow and to reduce the long-term paten-
cy rates by reducing the damage in the graft to the 
minimum level. It is known that the internal thoracic 
artery is the most commonly used graft due to its 
higher patency rates compared to venous grafts.
There is a medial layer, which is the excessive 
response to spasm by the RA. The spread of the 
RA use made it possible with the resolution of the 
vasospasm problem. Nowadays, it is the most fre-
quently used arterial graft after ITA [6]. In many 
cases, RA can be removed safely as the ulnar artery 
provides sufficient blood-flow. However, anomalies 
like the lack of ulnar artery and incomplete SPA or 
SPA receiving blood dominantly from the RA might 
occur in this respect. For this reason, the collateral 
circulation presence must be evaluated prior to the 
RA graft use. In practice, this is carried out with the 
Allen Test [5].
Today, the major SV continues to be the most 
preferred method in coronary artery ‘bypass’ sur-
gery with an ITA graft in many surgical centers [6]. 
The easy availability of the major SV as a graft, its 
easy removal, and its being resistant to spasm are 
considered as its advantages. On the other hand, it 
also has some disadvantages like low patency rates, 
diameter mismatch between the distal and proximal 
ends, varicosity, development of sclerosis, and espe-
cially in patients with peripheral arterial disease, the 
problems related to wound healing [7, 8]. 
Hypertension occurs frequently during and after 
CABG operations. The increased epinephrine and 
norepinephrine levels are held responsible for hy-
pertension [9]. In the treatment of hypertension, 
metaprolol sulfate, esmolol hydrochloride, nitroprus-
side sodium and isosorbide mononitrate perfusions 
are known to be used as the main agents; however, 
the effects of these agents on grafts are not known 
at an adequate level. Metaproterenol sulfate has 
selective bronchodilator and beta mimetic effects. It 
is very effective in controlling the intubation, brady-
cardia and hypertension that occur in bypass surgery 
during catheterization. However, it must not be used 
for prophylaxis. The aim of the present study was to 
determine whether metaproterenol sulfate could be 
used safely in CABG operations by examining the 
effects of it on coronary grafts.
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MATERIAL AND METHODS
This cross-sectional, prospective study was conduct-
ed at Namık Kemal University Hospital, Tekirdağ, 
Turkey. This University hospital has a capacity of 
1042 beds. The daily number of application to cardi-
ovascular surgery polyclinic is about 50 patients; and 
the annual number of patients undergoing CABG 
surgery is about 240. After the approval of the 
Ethics Committee of Namık Kemal University, Fac-
ulty of Medicine with the number NKUBAP.00.20.
TU.13.02, and after obtaining metaproterenol sul-
fate that would be used in in-vitro organ bath by the 
team that was responsible for the study, the study 
was initiated. In this study, ITA, RA and SV graft 
materials were studied in organ bath in patients 
who underwent CABG surgery between January 1, 
2013 and December 31, 2016 (3 years). Written 
informed consent was obtained from all the partici-
pants who were included in the study. The inclusion 
criteria of the study were being older than the age 
of 18, having undergone CABG surgery, being a pa-
tient with ITA, RA and SV graft materials, and being 
volunteers to participate in the study. 
The CABG operation was performed in all pa-
tients who participated in the study by providing 
hypothermic CPB and cardiac arrest at NKUTF Car-
dio-Vascular Surgery Clinic. The ITA, RA and SV were 
used as graft in these patients. The internal thoracic 
artery was removed with pedicles with the help 
of electrocautery and scissors. 
Titanium hemoclip was used to connect the side 
branches. The internal thoracic artery was cut after 
bifurcation. The superior epigastric artery (SEA) and 
the musculophrenic artery (MFA) branches in the 
distal area were clipped. The ITA part was taken 
without applying papaverine on the internal thoracic 
artery. In all patients, after the ITA was removed and 
prepared for anastomosis during the operation, the 
distal part that was removed was used. After the SV 
was removed with pedicles by dissection with scis-
sors, the saphena was taken without inflating with 
SF. In selecting the RA graft, first the non-dominant 
arm was preferred; and the Allen Test was applied 
to the patients to evaluate the ulnar artery collateral 
circulation. The RA was not excised in patients who 
had RA cannulation history, subclavian patency, in-
adequate ulnar circulation, and who needed arterio-
venous fistula for hemodialysis. After the radial-ul-
nar artery bifurcation discrimination, and following 
its removal in skeletonized form by clipping its side 
branches as of the wrist proximal area during the 
operation, the remaining RA part was taken by dis-
secting it from the distal segment. The RA and ITA 
were excised with the help of cautery and scissors 
together with adjacent vein, fascia and surrounding 
fat tissue. 
After the grafts were excised, they were not ex-
posed to any vasodilator agents of any form during 
the preparation stage. Once they were prepared as 
graft, the remaining 1-cm parts of the ITA, RA and 
SV were taken into Petri dishes that contained +4ºC 
Krebs Solution without any process. Then, they were 
brought to the laboratory at NKUTF Coronary Ar-
tery Surgery. The composition of the Krebs Solution 
(mM) was: NaCl 122, KCl 5; CaCl2 1.25; NaHCO3 25; 
MgSO4 1.2; KH2PO4 1.0; glucose 11.5. The grafts 
were dissected into 2-mm long sections by clearing 
the surrounding tissues in the light microscope at 
22°C room temperature, and were suspended hori-
zontally in the isometric transducer (FDT10-A, COM-
MAT, Turkey) with a plating hook in organ bath that 
included 10 ml Krebs Solution aired with carbogene 
(95% O2 + 5% CO2) at 37°C; and 2 gram pre-elon-
gation was applied. The responses were transferred 
to the computer through 4-channel Transducer Ac-
quisition System (COMMAT TDA-10-A, COMMAT, 
Turkey) and were recorded in POLWIN97 Program. 
For the adjustment of the tissues, washing was car-
ried out every 10 minutes; the pre-elongation was 
set at 2 grams; and 90 minutes passed in this con-
dition. To test the firmness of the vein endothelium, 
acetylcholine (10-6 M) was administered to the pre-
pared samples that were contracted submaximally 
with phenylephrine (10-6 M) to test whether relax-
ation response existed. The samples that did not 
yield adequate relaxation response were excluded 
from the study. 
The parts that were prepared at the beginning 
and at the end of the experiment were stimulated 
to receive their control responses. At the end of the 
experiment, in the control responses, the data that 
were obtained in the samples that showed signif-
icant amplitude reduction compared to the initial 
control responses at the beginning of the experi-
ment were excluded from the analyses. To ensure 
standardization in the evaluation of the responses, 
all the responses were calculated over the percent-
age in the control traces that were obtained initially. 
The metaproterenol sulfate (Boehringer Ingel-
heim-Alupent), which was purchased with the sup-
port of the researchers, and the potassium hydro-
chloride (Sigma) and phenylephrine (Sigma), which 
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were already present at the Cardio-Vascular Sur-
gery Department, were used in the experiment. The 
molarity calculations of these substances that were 
needed in the experiments were adjusted by weigh-
ing at precision scale (Mettler Toledo, AB 304-5). 
All the agents were prepared by dissolving them in 
distilled water. In the organ bath, the drug injec-
tions were applied with Eppendorf adjustable pipets 
(10–100 μL, 100–1000 μL). In the ITA, RA and SV 
samples, the dose responses of the metaproterenol 
sulfate were taken with the cumulative method, and 
the dose response curves were obtained. Then, the 
effects of metaproterenol sulfate were examined 
according to the responses received. 
In the organ bath, 10-6 phenylephrine was add-
ed to the grafts to ensure that the ITA, RA and SV 
grafts contracted submaximally. Then, by adding 
metaproterenol sulfate at rates that varied between 
10-8 and10-4 M (the cumulative method),the result-
ing relaxation results were rated to the relaxation 
with the phenylephrine contraction to create the 
dose-response curves. 
Statistical analysis
The Graphpad Prism 6 program was used in the 
analyses of the data. The concentration-response 
graphics were obtained with this program that in-
cluded statistical analysis in it. The non-linear regres-
sion analysis (variable slope) and the one-way ANO-
VA were applied to the graphics. The p < 0.05 was 
considered as significant in statistical analyses. 
RESULTS
A total of 30 patients, 15 (50%) of whom were 
males and 15 (50%) of whom were females, were 
included in the present study. The average age of the 
participants was 59.3 (45–81 years of age).The av-
erage age of the female patients was 60.6 (45–72), 
and that of the males was 58 (48–81). No statisti-
cally significant differences were detected between 
the genders in terms of age (p > 0.05). 
Minimum 1 and maximum 6 grafts (2.96 on 
average) were taken from all patients. The number 
of the left ITAs that were taken as graft was 30; the 
number of RAs was 13; and the number of SVs was 
25. No grafts were taken from the right ITA. The 
average partial by-pass time of the cases was deter-
mined to be 55.7 min. (27–110), and the total by-
pass time was determined to be 86.2 min. (35–140). 
Relaxation response was formed in the ITA at 
a rate of 40.49% ± 13.52 by adding metaprotere-
nol sulfate with the cumulative method. By rating 
this relaxation to submaximal contraction, the re-
laxation dose-response curves were created for the 
ITA (Figure 1). With a similar method, the relaxation 
response in the RA was determined to be at a rate 
of 28.41% ± 9.08. The dose-response curve that 
was prepared for the RA graft is given in Figure 2. In 
the statistical work that was done by comparing 
the relaxation values between the ITA grafts and RA 
grafts, it was observed that there was no significant 
difference between the efficacy of metaproterenol 
sulfate on these two grafts (p > 0.05). 
The rate of the relaxation that was caused in 
the SV as a response to metaproterenol sulfate 
that was added with the cumulative method was 
23.87% ± 8.36. The dose-response curve that was 
created for the SV graft is given in Figure 3. In 
the statistical work that was done by comparing 
fIGURE 1. The dose-response curve for internal thoracic artery 
graft
fIGURE 2. The dose-response curve for radial artery graft
Metoproterenol sulfate (-log M)
Metoproterenol sulfate (-log M)
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the relaxation values among the SV grafts, ITA and 
RA grafts, it was determined that the efficacy of 
metaproterenol sulfate in the SV grafts was signifi-
cantly lower when compared with the ITA and RA 
grafts (p < 0.05) (Figure 4). 
DISCUSSION
Cardiac surgery has rapidly improved in the past 
5 decades. The CABG surgery, which was mostly 
carried out with SV grafts, was preferred after 1980s 
because of the better long-term effects of the arteri-
al grafts. The purpose is to provide adequate blood-
flow to the ischemic area in the heart in bypass 
operations, which are used widely in our present 
day. The patency rates of autogenous grafts that are 
used for this purpose are related directly to the qual-
ity of life of the patient and the success of the CABG 
surgery. The patency rates in autogenous grafts are 
related closely with the damage on the endothelium 
during the removal process, and with the vasodilator 
agents employed in the postoperative period. The 
grafts that are used mostly in CABG operations are 
the ITA, RA and SV grafts [10, 11]. The grafts used 
in our study were the ITA, SV and RA grafts in line 
with the literature.
The idea that graft vasospasm might occur 
during CABG operations, and that this vasospasm 
might occur more in the RA caused that some sur-
geons had worries in this respect, which has become 
an important problem in the agenda [12]. The va-
sospasm in ‘by-pass’ grafts is associated with the 
damage to the vessel wall during removal and im-
plantation. It is already known that the vasospasm 
is less in venous grafts. In studies conducted with 
SV grafts, the reason for this was claimed to be the 
extremely low- or even none- basal production or 
release of nitric oxide [13]. In arterial grafts, it was 
shown in previous studies that the nitric oxide re-
lease was higher than that in the venous grafts; and 
for this reason, the patency durations were longer. 
However, the thing that is important here is that if 
maximum care is not given during graft removal, 
nitric oxide production will decrease, and patency 
rates because of vasospasm will also decrease [14]. 
One of the most important reasons for early graft 
failure is the vasospasm [15]. Although the exact 
mechanism of vasospasm has not yet been clarified, 
ischemia, hypoxia and vasoconstrictor agents play 
important roles in the vasospasm mechanism. In 
addition, the increase in the surgical manipulation 
and vascular smooth muscle hyperactivity, biochem-
ical and molecular factors as well as other factors 
[16], such as physical and pharmacological stimuli, 
are held responsible for this. It is possible that va-
sospasm occurs together with one or more of these 
factors [17]. As a result, perioperative morbidity, 
postoperative myocardial insufficiency and death 
may occur [18]. For this reason, the search has start-
ed for an agent that might prevent vasospasm. The 
effects of vasodilation agents on arterial grafts de-
pend on the reason of vasoconstriction. If contrac-
tion is caused by potassium, which is a depolarizing 
agent, nifedipine and other calcium-channel antag-
onists are highly effective in achieving relaxation. 
The reason for this is that the depolarizing agent 
potassium causes contraction by ensuring that the 
calcium-mediated calcium channels are blocked by 
calcium antagonists. However, it is less effective in 
preventing the receptor-mediated contraction. For 
the first time in 1971, Green et al. reported that pa-
fIGURE 3. The dose-response curve for saphenous vein graft
fIGURE 4. Comparison of the relaxation curves for in-vitro 
treatment with metaproterenol sulfate of internal thoracic artery, 
radial artery and saphenous vein grafts
Metoproterenol sulfate (-log M)
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paverine might be employed for this purpose; how-
ever, the search for other agents continued because 
it was not suitable for systemic use [3]. Papaverine 
has an effect on expanding blood vessels through 
multiple mechanisms of action, and is a non-specific 
vasodilator which is generally used topically. It is not 
suitable for systemic use because of its hypotension 
effect. It shows its real effect mechanism by increas-
ing the intracellular cGMP level with phosphodi-
esterase inhibition [19]. It also acts by inhibiting 
the calcium intake to the cell and the secretion of 
calcium that is stored in the cytosol [19]. Thanks to 
this characteristic, it has been argued that it caused 
vasodilatation at a sufficient level in arterial grafts; 
and it is still used for this purpose in our present 
time [20]. The most important problem about the 
local use of papaverine is that it has a strong acidic 
structure. It was determined that it causes damage 
to the endothelial structure because of its strong 
acidic structure. While its topical application on ad-
ventitia layer is effective, its intraluminal use must 
be avoided because it might harm the endotheli-
al structure. Nilia et al. reported that vasodilator 
agents might be required right after the removal of 
the graft [21]. Chanda and Canver reported in their 
studies that was conducted in 2001 that nitroglyc-
erin might be employed in addition to agents like 
papaverine, nifedipine, verapamil, diltiazem that are 
all employed as vasodilator agents [22]. For this 
reason, organic nitrates such as nitroglycerin and 
sodium nitroprusside are currently used in CABG 
surgery. The mechanisms of action are known to in-
crease the intracellular cGMP levels via the activation 
of guanylate cyclase in vascular smooth muscle cells 
depending on NO release. As a result, the levels of 
cytosolic calcium decreases, and relaxation occurs in 
the smooth muscle cells. In several studies that were 
conducted on arterial grafts, it was proven that they 
are effective vasodilators [23]. Among the calcium 
antagonists, which are divided into 3 groups ac-
cording to their chemical characteristics, the calcium 
antagonist that has the weakest effect is known as 
the diltiazem [24]. As nifedipine, which is a more 
potent agent, does not have any intravenous form, 
verapamil and diltiazem are still being used [25]. 
Metaproterenol sulfate, which is one of the drugs 
that are employed in the management of hyper-
tension, which appears before us during and after 
CABG surgeries, activates the adenylate cyclase, and 
provides dilatation by increasing the cAMP. How-
ever, no studies have been conducted on the ef-
fects of this drug on grafts. Selective beta-mimetic 
effective metaproterenol sulfate might accelerate 
the atrioventricular conduction, and increase the 
cardiac outflow, and therefore cause tachycardia 
and dilatation of coronary arteries. In our study, 
relaxation response was obtained in all grafts with 
metaproterenol sulfate. Among these grafts, the 
highest relaxation response was obtained with the 
IMA graft, and the lowest relaxation response was 
observed in the SV graft.
Study limitations
The present study of ours has several limitations. The 
first limitation is the issue of whether the maximum 
relaxation that occurred due to metaproterenol sul-
fate because of high nitric oxide release in the ITA 
grafts mentioned in previous studies would be re-
ferred only to this drug or to the excessively-released 
nitric oxide. There is a need for studies at receptor 
level that will be conducted with endothelium and 
in de-endothelized fashion to clarify this issue. Aside 
from these, the limited number of patients, and the 
fact that the study was a single-centered one are 
other limitations of the present study.
CONCLUSIONS
In the present study, when the relaxation rates that 
were formed on the ITA, RA and SV grafts after 
maximal contraction with the addition of metapro-
terenol sulfate with Cumulative Method was con-
sidered, it was concluded that the risk of devel-
oping vasospasm was low in all three grafts when 
metaproterenol sulfate is used in intraoperative and 
postoperative periods. However, in the long-term, 
this made us consider that better graft patency 
rates might be obtained. Multicenter in-vivo studies 
with larger patient groups are needed to support 
our findings.
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